Altium Capital Management »

Spruce Biosciences shares owned by Altium Capital Management

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $420k 811k 0.52
2024-03-31 $904k 1.2M 0.79

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Spruce Biosciences

RiverVest Venture Management
Carlyle
Rock Springs Capital Management
Acadian Asset Management
Vanguard Group
Altium Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
683 Capital Management
BlackRock
Bridgeway Capital Management
Superstring Capital Management
Lion Point Capital

View all funds holding Spruce Biosciences